Tag: Prescription Drugs

Two trials show lower amyloid plaque burden with gantenerumab versus placebo at 116 weeks

Reduction seen in risk for developing composite kidney outcome

Overall survival benefit demonstrated among patients with metastatic breast cancer who had received trastuzumab and taxanes

Greater incidence of grade 3 or higher adverse events from any cause seen in combination group versus monotherapy

Improvement in overall survival seen for patients receiving cisplatin or carboplatin with pemetrexed

Both visceral adipose percentage and infliximab levels independently tied to steroid-free deep remission

Decreases seen at week 12, with most of the decrease achieved at two and four weeks after cessation of combined hormonal contraceptives

Findings seen over three years in adults with preexisting cardiovascular disease and overweight or obesity

Considerable shortages of 2.5, 10 mg minoxidil reported by pharmacies in Washington, D.C., Maryland, and Virginia

Few eyes with no or background DR or mild or moderate NPDR have worsening of DR at three, six, 12, 24 months